MRTX1133

Based on 1 reference(s) in Google Scholar 8 10 1

Axon 3761

CAS [2621928-55-8]

MF C33H31F3N6O2
MW 600.63

  • Purity: 99%
  • Optical purity: 99%
  • Soluble in DMSO
Recently added

MRTX1133

Description

MRTX1133 is a first-in-class, noncovalent, selective & reversible inhibitor of KRASG12D mutant in both active and inactive states. Demonstrates selective inhibition of cell viability of KRASG12D mutant, but not KRAS wild-type, tumor cells. Displays sustained dose-dependent inhibition of KRAS-dependent signaling in mouse tumor models.

* Sold in collaboration with Chemietek.

KEYWORDS: MRTX1133 | Supplier | KRASG12D mutant inhibitor | MRTX 1133 | MRTX-1133 | CT-MTX1133 | CAS [2621928-55-8] | GTP | KRAS | Inhibitor | Enzymes

First-in-class, noncovalent, selective & reversible inhibitor of KRASG12D mutant

Chemical name

4-(4-(3,8-Diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-(((2R,7aS)-2-fluorohexahydro-1H-pyrrolizin-7a-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-ol

Source information

Sold in collaboration with Chemietek

Parent CAS No.

[2621928-55-8]

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...